Rowan R M, Gordon A M, Chaudhuri A K, Moran F
Br Med J. 1974 Aug 3;3(5926):317-9. doi: 10.1136/bmj.3.5926.317.
The nitroblue tetrazolium (N.B.T.) test was performed on patients in whom a differential diagnosis of pulmonary thromboembolism or lobar pneumonia existed. The mean N.B.T. score in healthy subjects was 6.4% (range 1%-15%). Patients with uncomplicated pulmonary thromboembolism showed a mean N.B.T. value of 7.5% (range 3%-12%). In patients with lobar pneumonia the mean N.B.T. score was 42.4% (range 21%-85%). These results suggest that the N.B.T. test is of value in the differential diagnosis of pulmonary thromboembolism and lobar pneumonia.
对存在肺血栓栓塞症或大叶性肺炎鉴别诊断的患者进行了硝基四氮唑蓝（N.B.T.）试验。健康受试者的平均N.B.T.评分是6.4%（范围为1%-15%）。无并发症的肺血栓栓塞症患者的平均N.B.T.值为7.5%（范围为3%-12%）。大叶性肺炎患者的平均N.B.T.评分是42.4%（范围为21%-85%）。这些结果表明，N.B.T.试验在肺血栓栓塞症和大叶性肺炎的鉴别诊断中具有价值。
